Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Apr 3;10:531–551. doi: 10.2147/JHC.S400472

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2023 Dai et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

Validation of ST6GALNAC4 expression in HCC tissues and its correlation with immune checkpoints. (A) Expression profile of ST6GALNAC4 in 47 HCC tissues compared to paracan-cerous tissues. (B) The mean expression level of ST6GALNAC4 in 47 paired HCC and paracan-cerous tissues (**p < 0.01). (C) The relative expression distribution of ST6GALNAC4, PD-L1, and B7-H3 in HCC tissues. (D) Correlation analyses of ST6GALNAC4 expression with PD-L1 and B7-H3 in HCC tissues. (E) Western blot analysis for ST6GALNAC4 protein expression in HCC and paracancerous tissues.

Abbreviations: HCC, hepatocellular carcinoma; PD-L1, programmed cell death-1 ligand 1.